Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

NCT00605410 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT00605410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00605410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
April 30, 2008
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma